Karalok Alper, Ureyen Isin, Tasci Tolga, Basaran Derman, Turkmen Osman, Boran Nurettin, Cirik Derya Akdag, Kimyon Gunsu, Tulunay Gokhan, Turan Taner
Gynecologic Oncology Department, Etlik Zubeyde Hanim Women's Health Teaching and Research Hospital, Ankara - Turkey.
Tumori. 2016 Aug 3;102(4):404-8. doi: 10.5301/tj.5000510. Epub 2016 May 9.
Adult granulosa cell tumor (AGCT) of ovary is a rare tumor and usually has a benign course. Due to its indolent nature, recurrences are observed in a wide period and data on management of recurrences in AGCT are relatively sparse. We aimed to evaluate the clinical features, management, and survival of patients with recurrent AGCT.
The data of 144 patients with AGCT treated in Etlik Zubeyde Hanim Teaching and Research Hospital between 1990 and 2013 were retrospectively evaluated. Patients with radiologic or pathologic recurrences were included in the analysis.
A total of 18 patients (12.5%) with recurrent AGCT were included. Median follow-up was 97.5 months (range 6-255 months). A total of 16 patients underwent salvage surgery and maximal debulking was achieved in 13 patients. Ten patients had unifocal and 8 had multifocal tumors. Maximal debulking could be achieved in all patients with unifocal recurrence. On the other hand, maximal debulking could only be obtained in 3 patients (37%) with multifocal recurrence (p = 0.031). Multifocality of recurrent disease and the presence of residual tumor after surgery were associated with diminished progression-free survival and overall survival (31 vs 207 months, p = 0.031; and 22 vs 220 months, p = 0.005, respectively).
Multifocal recurrence and suboptimal surgery were related with poor survival outcomes in patients with AGCT recurrence. Surgical treatment of recurrent AGCT should aim to achieve no visible disease.
卵巢成人颗粒细胞瘤(AGCT)是一种罕见肿瘤,通常病程呈良性。由于其惰性特点,复发可在较长时间内出现,且关于AGCT复发管理的数据相对较少。我们旨在评估复发性AGCT患者的临床特征、治疗及生存情况。
回顾性评估1990年至2013年在埃特利克祖贝德哈尼姆教学与研究医院接受治疗的144例AGCT患者的数据。纳入影像学或病理学复发的患者进行分析。
共纳入18例复发性AGCT患者(12.5%)。中位随访时间为97.5个月(范围6 - 255个月)。共有16例患者接受了挽救性手术,13例患者实现了最大程度肿瘤细胞减灭。10例患者为单灶性肿瘤,8例为多灶性肿瘤。所有单灶性复发患者均能实现最大程度肿瘤细胞减灭。另一方面,多灶性复发患者中只有3例(37%)能实现最大程度肿瘤细胞减灭(p = 0.031)。复发性疾病的多灶性以及手术后残留肿瘤与无进展生存期和总生存期缩短相关(分别为31个月对207个月,p = 0.031;22个月对220个月,p = 0.005)。
多灶性复发和手术效果欠佳与AGCT复发患者的不良生存结局相关。复发性AGCT的手术治疗应旨在实现无可见病灶。